Anti-IGSF8 antibody
Specifications
| Product Cat#: | AB-06-2372 |
| Product type: | Primary antibody |
| Antigen: | IGSF8 |
| Immunogen: | KLH conjugated synthetic peptide derived from mouse IGSF8 101-200/611 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:800-1:2000); Flow Cytometry (1-2 ug/Test) |
| Reactivity: | Mouse, Rat, Pig, Cow, Horse and Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | CD316 |
| CD316 antigen | |
| CD81 partner 3 | |
| CD81P3 | |
| EWI-2 | |
| EWI2 | |
| Glu-Trp-Ile EWI motif-containing protein 2 | |
| Igsf-8 | |
| IgSF8 | |
| IGSF8_MOUSE | |
| Immunoglobulin superfamily member 8 | |
| Immunoglobulin superfamily member 8 precursor | |
| KCT-4 | |
| KCT4 | |
| Keratinocytes-associated transmembrane protein 4 | |
| LIR-D1 | |
| PGRL |
Show More
Target information
May play a key role in diverse functions ascribed to CD81 and CD9 such as oocytes fertilization or hepatitis C virus function. May regulate proliferation and differentiation of keratinocytes. May be a negative regulator of cell motility: suppresses T-cell mobility coordinately with CD81, associates with CD82 to suppress prostate cancer cell migration, regulates epidermoid cell reaggregation and motility on laminin-5 with CD9 and CD81 as key linkers. May also play a role on integrin-dependent morphology and motility functions. May participate in the regulation of neurite outgrowth and maintenance of the neural network in the adult brain.
Provider
Erpantech Laboratory
